Please enable JavaScript to continue using this application.

Compare $CBUS vs $PMVP | Chartloom

Compare

$CBUS vs $PMVP

Cibus Inc · PMV Pharmaceuticals Inc

CBUS

Cibus Inc

PMVP

PMV Pharmaceuticals Inc

Compare $CBUS vs $PMVP

Comparing Cibus Inc and PMV Pharmaceuticals Inc

CBUSCibus Inc

PMVPPMV Pharmaceuticals Inc

CBUSCibus Inc

Market cap

$118M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

12.82x

Rev growth (TTM)

-10.3%

YTD performance

-17.6%

52W performance

5.4%

FCF yield

-39.2%

PMVPPMV Pharmaceuticals Inc

Market cap

$81M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

23.6%

52W performance

7.0%

FCF yield

-87.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CBUS

PMVP

Detailed metrics comparison

CBUS

Cibus Inc

PMVP

PMV Pharmaceuticals Inc

Market Cap

CBUS$118M

PMVP$81M

Enterprise Value

CBUS$352M

PMVP$69M

Price

CBUS$1.55

PMVP$1.52

P/E Ratio

CBUSN/A

PMVPN/A

P/S Ratio

CBUS27.22x

PMVP0.00x

EV/Sales

CBUS81.04x

PMVP0.00x

EV/EBITDA

CBUS0.00x

PMVP0.00x

P/B Ratio

CBUS8.83x

PMVP1.89x

P/FCF Ratio

CBUSN/A

PMVPN/A

EV/FCF

CBUS-7.59x

PMVP-0.96x

PEG Ratio

CBUSN/A

PMVPN/A

Forward P/E (NTM)

CBUSN/A

PMVPN/A

Forward P/S (NTM)

CBUS12.82x

PMVPN/A

Revenue (TTM)

CBUS$4M

PMVP$0

Revenue Growth (YoY)

CBUS-10.3%

PMVPN/A

Forward Rev Growth

CBUS139.3%

PMVP546.2%

Gross Margin (TTM)

CBUS100.0%

PMVP0.0%

Operating Margin (TTM)

CBUS0.0%

PMVP0.0%

EBITDA Margin (TTM)

CBUS-1124.2%

PMVP0.0%

Net Margin (TTM)

CBUS-2258.9%

PMVP0.0%

FCF Margin (TTM)

CBUS-1067.5%

PMVPN/A

Net Income (TTM)

CBUS$-98M

PMVP$-75M

FCF (TTM)

CBUS$-46M

PMVP$-71M

EPS (TTM)

CBUS-$1.28

PMVP-$1.41

ROE (TTM)

CBUS-32060.0%

PMVP-7811.0%

ROA (TTM)

CBUS-3086.0%

PMVP-7013.0%

ROIC (TTM)

CBUS-3627.0%

PMVP-7811.0%

Cash

CBUS$20M

PMVP$12M

Debt

CBUS$254M

PMVP$0

Net Cash/Debt

CBUS$-234M

PMVP$12M

Current Ratio (TTM)

CBUS1.62x

PMVP7.70x

Quick Ratio (TTM)

CBUS1.47x

PMVP7.52x

Debt/Equity (TTM)

CBUS17.19x

PMVP0.00x

Debt/Assets (TTM)

CBUS0.0%

PMVP0.0%

Interest Coverage (TTM)

CBUSN/A

PMVPN/A

Net Debt/EBITDA (TTM)

CBUS0.00x

PMVP0.00x

Beta

CBUS1.70

PMVP1.48

52W Performance

CBUS5.4%

PMVP7.0%

YTD Performance

CBUS-17.6%

PMVP23.6%

% from 52W High

CBUS-63.0%

PMVP-20.4%

% from 52W Low

CBUS42.2%

PMVP49.0%

Asset Turnover (TTM)

CBUS0.01x

PMVP0.00x

FCF Yield (TTM)

CBUS-39.2%

PMVP-87.9%

Earnings Yield (TTM)

CBUS-83.0%

PMVP-92.8%

Dividend Yield (TTM)

CBUSN/A

PMVPN/A

Rule of 40

CBUS-1,077.8

PMVP0.0

EV/GP/RG

CBUS0.72

PMVPN/A

Ticker research

View CBUS research View PMVP research

Metric	CBUS Cibus Inc	PMVP PMV Pharmaceuticals Inc
Market & Valuation
Market Cap	$118M	$81M
Enterprise Value	$352M	$69M
Price	$1.55	$1.52
P/E Ratio	N/A	N/A
P/S Ratio	27.22x	0.00x
EV/Sales	81.04x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	8.83x	1.89x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.59x	-0.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.82x	N/A
Revenue & Growth
Revenue (TTM)	$4M	$0
Revenue Growth (YoY)	-10.3%	N/A
Forward Rev Growth	139.3%	546.2%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1124.2%	0.0%
Net Margin (TTM)	-2258.9%	0.0%
FCF Margin (TTM)	-1067.5%	N/A
Net Income (TTM)	$-98M	$-75M
FCF (TTM)	$-46M	$-71M
EPS (TTM)	-$1.28	-$1.41
ROE (TTM)	-32060.0%	-7811.0%
ROA (TTM)	-3086.0%	-7013.0%
ROIC (TTM)	-3627.0%	-7811.0%
Financial Health
Cash	$20M	$12M
Debt	$254M	$0
Net Cash/Debt	$-234M	$12M
Current Ratio (TTM)	1.62x	7.70x
Quick Ratio (TTM)	1.47x	7.52x
Debt/Equity (TTM)	17.19x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.70	1.48
52W Performance	5.4%	7.0%
YTD Performance	-17.6%	23.6%
% from 52W High	-63.0%	-20.4%
% from 52W Low	42.2%	49.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-39.2%	-87.9%
Earnings Yield (TTM)	-83.0%	-92.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,077.8	0.0
EV/GP/RG	0.72	N/A
Ticker research	View CBUS research	View PMVP research

Valuation

P/S Ratio

PMVP

0.00x

CBUS

27.22x

EV/FCF

CBUS

-7.59x

PMVP

-0.96x

Growth & revenue

Revenue Growth TTM

CBUS

-10.3%

Forward Revenue Growth

PMVP

546.2%

CBUS

139.3%

Profitability & performance

Gross Margin

CBUS

100.0%

PMVP

0.0%

ROE

PMVP

-7811.0%

CBUS

-32060.0%

FCF Yield %

CBUS

-39.2%

PMVP

-87.9%

52-Week Performance

PMVP

7.0%

CBUS

5.4%

Detailed metrics comparison

CBUS

Cibus Inc

PMVP

PMV Pharmaceuticals Inc

Market Cap

CBUS$118M

PMVP$81M

Enterprise Value

CBUS$352M

PMVP$69M

Price

CBUS$1.55

PMVP$1.52

P/E Ratio

CBUSN/A

PMVPN/A

P/S Ratio

CBUS27.22x

PMVP0.00x

EV/Sales

CBUS81.04x

PMVP0.00x

EV/EBITDA

CBUS0.00x

PMVP0.00x

P/B Ratio

CBUS8.83x

PMVP1.89x

P/FCF Ratio

CBUSN/A

PMVPN/A

EV/FCF

CBUS-7.59x

PMVP-0.96x

PEG Ratio

CBUSN/A

PMVPN/A

Forward P/E (NTM)

CBUSN/A

PMVPN/A

Forward P/S (NTM)

CBUS12.82x

PMVPN/A

Revenue (TTM)

CBUS$4M

PMVP$0

Revenue Growth (YoY)

CBUS-10.3%

PMVPN/A

Forward Rev Growth

CBUS139.3%

PMVP546.2%

Gross Margin (TTM)

CBUS100.0%

PMVP0.0%

Operating Margin (TTM)

CBUS0.0%

PMVP0.0%

EBITDA Margin (TTM)

CBUS-1124.2%

PMVP0.0%

Net Margin (TTM)

CBUS-2258.9%

PMVP0.0%

FCF Margin (TTM)

CBUS-1067.5%

PMVPN/A

Net Income (TTM)

CBUS$-98M

PMVP$-75M

FCF (TTM)

CBUS$-46M

PMVP$-71M

EPS (TTM)

CBUS-$1.28

PMVP-$1.41

ROE (TTM)

CBUS-32060.0%

PMVP-7811.0%

ROA (TTM)

CBUS-3086.0%

PMVP-7013.0%

ROIC (TTM)

CBUS-3627.0%

PMVP-7811.0%

Cash

CBUS$20M

PMVP$12M

Debt

CBUS$254M

PMVP$0

Net Cash/Debt

CBUS$-234M

PMVP$12M

Current Ratio (TTM)

CBUS1.62x

PMVP7.70x

Quick Ratio (TTM)

CBUS1.47x

PMVP7.52x

Debt/Equity (TTM)

CBUS17.19x

PMVP0.00x

Debt/Assets (TTM)

CBUS0.0%

PMVP0.0%

Interest Coverage (TTM)

CBUSN/A

PMVPN/A

Net Debt/EBITDA (TTM)

CBUS0.00x

PMVP0.00x

Beta

CBUS1.70

PMVP1.48

52W Performance

CBUS5.4%

PMVP7.0%

YTD Performance

CBUS-17.6%

PMVP23.6%

% from 52W High

CBUS-63.0%

PMVP-20.4%

% from 52W Low

CBUS42.2%

PMVP49.0%

Asset Turnover (TTM)

CBUS0.01x

PMVP0.00x

FCF Yield (TTM)

CBUS-39.2%

PMVP-87.9%

Earnings Yield (TTM)

CBUS-83.0%

PMVP-92.8%

Dividend Yield (TTM)

CBUSN/A

PMVPN/A

Rule of 40

CBUS-1,077.8

PMVP0.0

EV/GP/RG

CBUS0.72

PMVPN/A

Ticker research

View CBUS research View PMVP research

Metric	CBUS Cibus Inc	PMVP PMV Pharmaceuticals Inc
Market & Valuation
Market Cap	$118M	$81M
Enterprise Value	$352M	$69M
Price	$1.55	$1.52
P/E Ratio	N/A	N/A
P/S Ratio	27.22x	0.00x
EV/Sales	81.04x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	8.83x	1.89x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.59x	-0.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.82x	N/A
Revenue & Growth
Revenue (TTM)	$4M	$0
Revenue Growth (YoY)	-10.3%	N/A
Forward Rev Growth	139.3%	546.2%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1124.2%	0.0%
Net Margin (TTM)	-2258.9%	0.0%
FCF Margin (TTM)	-1067.5%	N/A
Net Income (TTM)	$-98M	$-75M
FCF (TTM)	$-46M	$-71M
EPS (TTM)	-$1.28	-$1.41
ROE (TTM)	-32060.0%	-7811.0%
ROA (TTM)	-3086.0%	-7013.0%
ROIC (TTM)	-3627.0%	-7811.0%
Financial Health
Cash	$20M	$12M
Debt	$254M	$0
Net Cash/Debt	$-234M	$12M
Current Ratio (TTM)	1.62x	7.70x
Quick Ratio (TTM)	1.47x	7.52x
Debt/Equity (TTM)	17.19x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.70	1.48
52W Performance	5.4%	7.0%
YTD Performance	-17.6%	23.6%
% from 52W High	-63.0%	-20.4%
% from 52W Low	42.2%	49.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-39.2%	-87.9%
Earnings Yield (TTM)	-83.0%	-92.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,077.8	0.0
EV/GP/RG	0.72	N/A
Ticker research	View CBUS research	View PMVP research